¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"infection control nurse"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • infection source
    °¨¿°¿ø, Àü¿°¿ø
  • insect-borne infection
    °ïÃæ¸Å°³°¨¿°
  • intercurrent infection
    º´¹ß°¨¿°
  • latent infection
    Àẹ°¨¿°
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ¼º°¨¿°
  • lytic infection
    ¿ë±Õ°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
  • milk-borne infection
    ¿ìÀ¯¸Å°³°¨¿°
  • mixed infection
    È¥ÇÕ°¨¿°
  • mock infection
    ¸ðÀǰ¨¿°½ÇÇè
  • multiple infection
    º¹¼ö°¨¿°, ¿©·¯¹ø°¨¿°
  • mycotic infection
    °õÆÎÀ̰¨¿°, Áø±Õ°¨¿°
  • mass infection
    Áý´Ü°¨¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • generalized infection
    Àü½Å°¨¿°
  • germinal infection
    (¢¡heredoinfection) À¯Àü°¨¿°
  • hematogenous infection
    Ç÷Çà°¨¿°
  • herd infection
    Áý´Ü°¨¿°
  • herpes simplex infection
    ´Ü¼øÇ츣Æä½º°¨¿°
  • hospital acquired infection
    ¿ø³»°¨¿°, º´¿ø°¨¿°
  • household infection
    Áý¾È°¨¿°
  • infection
    °¨¿°
  • inapparant infection
    ¹«Áõ»ó°¨¿°, ºÒÇö¼º°¨¿°
  • indigenous infection
    ÅäÂø°¨¿°
  • indirect infection
    °£Á¢°¨¿°
  • infection immunity
    °¨¿°¸é¿ª
  • infection route
    °¨¿°°æ·Î
  • infection source
    °¨¿°¿ø, Àü¿°¿ø
  • insect-borne infection
    °ïÃæ¸Å°³°¨¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • infection, milk-borne
    À¯Á¦Ç°¸Å°³°¨¿°
  • infection, multiple
    ´ÙÁß°¨¿°, º¹¼ö±Õ°¨¿°
  • infection, mycotic
    Áø±Õ°¨¿°
  • infection, natural
    ÀÚ¿¬°¨¿°
  • infection, nosocomial
    ¿ø³»°¨¿°, º´¿ø³»°¨¿°
  • infection, odontogenic
    Ä¡¼º°¨¿°
  • infection, opportunistic
    ±âȸ°¨¿°
  • infection, oral
    ±¸°­°¨¿°
  • infection, oral focal
    ±¸°­º´¼Ò°¨¿°
  • infection, otic
    ÀÌ(¼º)°¨¿°
  • infection, persistent
    Áö¼Ó°¨¿°
  • infection, polymicrobial
    º¹¼ö±Õ°¨¿°, º¹¼ö¹Ì»ý¹°°¨¿°
  • infection, primary
    ÀÏÂ÷°¨¿°
  • infection, secondary
    ÀÌÂ÷°¨¿°
  • infection, slow virus
    Áö¹ß¹ÙÀÌ·¯½º°¨¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • sugar control
    ¼³ÅÁ¼·ÃëÁ¦ÇÑ(¡­àîö¢ð¤ùÚ).
  • sulfur dioxide control
    ÀÌ»êȭȲ°¡½º±ÔÁ¦(Ëö Ë×Ì´Ì·ÊÙ˻̡).
  • thought control
    »ç°íÅëÁ¦(~÷Öð¤).
  • time gain control
    ½Ã°£ (ãÁÊà) °ÔÀÎ Á¶Àý (ðàï½)
  • time gain control
    ½Ã°£ °ÔÀÎ Á¶Àý
  • tonic control
    °­Á÷¼º(Ë­òÁàõ) Á¦¾î
  • tonic control
    °­Á÷¼º(Ë­òÁàõ) Á¦¾î.
  • tuberculosis control
    °áÇÙ°ü¸®.
  • tuberculosis control
    °áÇÙ¿¹¹æ(Ë­Ì´ËçËÑ), °áÇÙ°ü¸®.
  • tumor control
    Á¾¾ç¾ïÁ¦
  • tumor control dose
    Á¾¾ç¾ïÁ¦¼±·®
  • tumor control probability, TCP
    Á¾¾ç¾ïÁ¦¿ï
  • venereal disease control
    ¼ºº´°ü¸®.
  • vestibuloequilibratory control
    ÀüÁ¤ÆòÇüÁ¶Àý(¡­øÁû¬ðàï½).
  • volitional control
    ÀÚ¹ßÀû Á¦¾î(¡­îÜð¤åÙ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
GII gastrointestinal infection
HOI hospital onset of infection
IAHS infection-associated hemophagocytic syndrome; International Association of Hospital Security
IAI intra-abdominal infection
ICI intracardiac infection
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
CRBSI Catheter-related bloodstream infection
CRI Catheter-related infection
CMV Cytomegalovirus infection
DPI Day post infection
DGI Disseminated Gonococcal Infection
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
fungal nail infection The most common fungus infection of the nail is onychomycosis. Onychomycosis makes the nails look white and opaque, thickened, and brittle. Older women (perhaps because oestrogen deficiency may increase the risk of infection) and men and women with diabetes or disease of the small blood vessels (peripheral vacscular disease) are at increased risk. Artificial nails (acrylic or wraps ) increase the risk because when an artificial nail is applied, the nail surface is usually abraded with an emery board damaging it, emery boards can carry infection, and water can collect under the nail creating a moist, warm environment for fungal growth. Alternative names include tinea unguium and ringworm of the nails.
(12 Dec 1998)
lysogenic infection An infective process characterised by the incorporation of the DNA of the infecting phage into the host cell chromosome. Once incorporated, the phage DNA replicates along with the host DNA. The incorporated phage DNA is relatively inactive, thus permitting the host cell to continue fairly normal life processes.
(14 Nov 1997)
lytic infection The normal cycle of infection of a cell by a virus or bacteriophage, in which mature virus or phage particles are produced and the cell is then lysed.
(18 Nov 1997)
acceptor control <biochemistry> The regulation of the respiration rate, governed by ADP's ability to be a phosphate group acceptor.
(06 May 1997)
anticipatory control <physiology> The regulation of a system or process based on anticipated events, this isa feed-forward rather than a feedback system.
(09 Oct 1997)
assist-control ventilation Artificial respiration in which inspiration is produced automatically after a set interval if the person has not already begun to inspire.
Compare: assisted ventilation, controlled ventilation.
(05 Mar 2000)
autogenous control <molecular biology> Regulation of how much a gene gets transcribed by the gene's own products.
(02 Jan 1998)
aversive control <psychology> Control of the behaviour of another individual by use of psychologically noxious means; e.g., attempting to force better study habits by withholding a child's allowance, or withholding sexual contact unless the partner complies with a request.
(05 Mar 2000)
biological control <agriculture> The agricultural use of living things, such as parasites, diseases, and predators, to control or eliminate others, such as weeds and pests, rather than by using chemicals (herbicides and pesticides).
(21 Mar 1998)
birth control Restriction of the number of offspring by means of contraceptive measures, projects, programs, or methods to control reproduction, by either improving or diminishing fertility.
(05 Mar 2000)
gate-control hypothesis A theory to explain the mechanism of pain; small fibre afferent stimuli, particularly pain, entering the substantia gelatinosa can be modulated by large fibre afferent stimuli and descending spinal pathways so that their transmission to ascending spinal pathways is blocked (gated).
Synonym: gate-control hypothesis.
(05 Mar 2000)
gate-control theory A theory to explain the mechanism of pain; small fibre afferent stimuli, particularly pain, entering the substantia gelatinosa can be modulated by large fibre afferent stimuli and descending spinal pathways so that their transmission to ascending spinal pathways is blocked (gated).
Synonym: gate-control hypothesis.
(05 Mar 2000)
case-control study <epidemiology> A study in which the risk factors of people with a disease are compared with those without a disease.
It is an epidemiological method that begins by identifying persons with the disease or condition of interest (the cases) and compares their past history of exposure to identified or suspected risk factors with the past history of similar exposures among persons who resemble the cases but do not have the disease or condition of interest (the controls).
The relationship of an attribute to the disease can therefore be examined by comparing affected and non-affected individuals with regard to the frequency or levels of the attribute in each group.
(05 May 2002)
vestibulo-equilibratory control Nerve impulses transmitted from the saemicircular canals, saccule, and utricle that serve to maintain the equilibrium of the body.
(05 Mar 2000)
reflex control Nerve impulses transmitted to the muscles to maintain normal reflex action.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á